CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 53 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -100.0% | 233 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $18,866,000 | -3.7% | 3,047,800 | 0.0% | 0.04% | -8.3% |
| Q2 2020 | $19,597,000 | +54.9% | 3,047,800 | 0.0% | 0.05% | +29.7% |
| Q1 2020 | $12,648,000 | +0.8% | 3,047,800 | +43.6% | 0.04% | +32.1% |
| Q4 2019 | $12,546,000 | +6.1% | 2,122,800 | -3.0% | 0.03% | -3.4% |
| Q3 2019 | $11,823,000 | -33.1% | 2,189,400 | 0.0% | 0.03% | -32.6% |
| Q2 2019 | $17,668,000 | +1.9% | 2,189,400 | 0.0% | 0.04% | 0.0% |
| Q1 2019 | $17,340,000 | +280.3% | 2,189,400 | +109.8% | 0.04% | +258.3% |
| Q4 2018 | $4,560,000 | – | 1,043,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 4,092,166 | $8,634,000 | 3.55% |
| COMMODORE CAPITAL LP | 1,617,000 | $3,412,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 1,173,674 | $2,476,000 | 0.99% |
| VR Adviser, LLC | 3,234,000 | $6,824,000 | 0.83% |
| Logos Global Management LP | 3,190,000 | $6,731,000 | 0.57% |
| Cormorant Asset Management, LP | 3,550,000 | $7,490,000 | 0.25% |
| Soleus Capital Management, L.P. | 775,000 | $1,635,000 | 0.25% |
| Perceptive Advisors | 15,374,370 | $32,438,000 | 0.21% |
| RA Capital Management | 5,947,861 | $12,550,000 | 0.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 188,777 | $398,000 | 0.18% |